Table 4.
SARS-CoV-2 Antibodies | ||||
---|---|---|---|---|
Overall (N= 40) | IgG+ | IgM+ | ||
N (%) | 27 (67.5) | 13 (32.5) | ||
Sex | Male | Female | Male | Female |
12 (44.4%) | 15 (55.6%) | 5 (38.5%) | 8 (61.5%) | |
Coinfection (N=19) | ||||
IgG-SARS-CoV-2 reactive in IgM-Measles virus-positive samples (N= 9) |
IgM-SARS-CoV-2 reactive in IgM-Measles virus-positive samples (N= 10) |
|||
Sex | 3 (33.3%) | 6 (66.7%) | 3 (30.0%) | 7 (70.0%) |